Jaguar Health Files 8-K on Key Corporate Changes

Ticker: JAGX · Form: 8-K · Filed: 2025-02-27T00:00:00.000Z

Sentiment: neutral

Topics: corporate-action, filing, legal-update

Related Tickers: JAGX

TL;DR

Jaguar Health (JAGX) filed an 8-K detailing major corporate changes and agreements.

AI Summary

On February 26, 2025, Jaguar Health, Inc. filed an 8-K report detailing several significant events. These include the entry into a material definitive agreement, material modifications to the rights of security holders, and amendments to its articles of incorporation or bylaws. The filing also covers other events and financial statements/exhibits.

Why It Matters

This filing indicates significant corporate actions by Jaguar Health, Inc., which could impact its structure, governance, and shareholder rights.

Risk Assessment

Risk Level: medium — The filing involves material definitive agreements and modifications to security holder rights, which can introduce new risks or alter existing ones.

Key Numbers

Key Players & Entities

FAQ

What specific material definitive agreement did Jaguar Health, Inc. enter into?

The filing indicates the entry into a material definitive agreement but does not specify the details of the agreement itself within the provided text.

What are the material modifications to the rights of security holders?

The filing states there were material modifications to the rights of security holders, but the specific nature of these modifications is not detailed in the provided text.

What amendments were made to Jaguar Health, Inc.'s articles of incorporation or bylaws?

The filing reports amendments to the articles of incorporation or bylaws, but the specific changes are not elaborated upon in the provided text.

What is the significance of the 'Other Events' item in this 8-K filing?

The 'Other Events' item suggests that Jaguar Health, Inc. is reporting events not covered by other standard 8-K items, the specifics of which are not detailed in the provided text.

When was Jaguar Health, Inc. formerly known as Jaguar Animal Health, Inc. and when did the name change occur?

Jaguar Health, Inc. was formerly known as Jaguar Animal Health, Inc., and the date of the name change was August 30, 2013.

From the Filing

0000950170-25-028403.txt : 20250227 0000950170-25-028403.hdr.sgml : 20250227 20250227084008 ACCESSION NUMBER: 0000950170-25-028403 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250226 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Material Modifications to Rights of Security Holders ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250227 DATE AS OF CHANGE: 20250227 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 25673216 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 8-K 1 jagx-20250226.htm 8-K 8-K false --12-31 0001585608 0001585608 2025-02-26 2025-02-26   UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025     Jaguar Health, Inc. (Exact name of Registrant as Specified in Its Charter)     Delaware 001-36714 46-2956775 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)           200 Pine Street Suite 400   San Francisco , California   94104 (Address of Principal Executive Offices)   (Zip Code)   Registrant’s Telephone Number, Including Area Code: (415) 371-8300     (Former Name or Former Address, if Changed Since Last Report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, Par Value $0.0001 Per Share   JAGX   The Nasdaq Stock Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐   Item 1.01 Entry into a Material Definitive Agreement. On February 26, 2025 the Board of Directors (the “Board”) of Jaguar Health, Inc. (the “Company”) declared a dividend of (i) one preferred share purchase right (a “Class A Right”) for each share of common stock, par value $0.0001 per share, of the Company (the “Common Stock”) and (ii) one preferred stock purchase right (a “Cla

View on Read The Filing